Delivery Order SPE2DB20D2104-SPE2DB23FS11A

Award Date 2/7/23
Potential Completion Date 2/8/23
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Mupirocin 2% Cream 15GM to the Defense Logistics Agency (DLA). The contract, valued at $2,799.53, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 19, 2023 with a completion date of May 22, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not associated with a set-aside program, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of Mupirocin 2% cream, a prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,869.29 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 5, 2023 with a completion date of June 6, 2023. The contract is a firm fixed price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,562.44, is for the delivery of 4566490563 - Mupirocin 2% Cream 15GM. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of November 20, 2024. The award date is November 19, 2024. This contract does not have a set-aside designation....
This federal contract award is for the delivery of Mupirocin 2% cream, a topical antibiotic medication, to the Defense Logistics Agency (DLA). The contract, valued at $6,091.08, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on August 27, 2024. The contract has a firm fixed price pricing type and an ultimate completion date of August 28, 2024. This contract award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Mupirocin 2% Cream 15gm, a pharmaceutical product, with a ceiling value of $2,181.41 and a completion date of April 19, 2023. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of Mupirocin 2% cream in 15 gram tubes to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,157.29 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of mupirocin 2% cream (15 gm). The contract has a firm fixed price of $2,168.80 and a period of performance through August 10, 2023. This is a delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award is for the delivery of Mupirocin 2% cream, a topical antibiotic medication, to the Defense Logistics Agency (DLA). The $1,096.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on August 29, 2023 with a completion date of August 30, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mupirocin 2% Cream in 15 gram tubes. The $1,649.38 Firm Fixed Price Delivery Order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award, valued at $2,679.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Mupirocin 2% Cream, a pharmaceutical product, to support military treatment facilities and other government healthcare programs. This award is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FS11A
    Delivery Order

This federal contract award is for the delivery of Mupirocin 2% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 7, 2023. The contract has a ceiling value of $3,330.90 and a completion date of February 8, 2023. The contract is a Delivery Order and has a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 1:11 PM